Jan 20 (Reuters) - McKesson Corp will replace some Moderna Inc COVID-19 vaccines in the United States after they arrived colder than the low end of the required temperature range, the company said in a statement on Wednesday. (Reporting by Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.8 USD | +1.56% | +6.35% | +8.45% |
Apr. 24 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
Apr. 24 | Moderna to Collaborate With OpenAI to Launch New Generation of Medicines | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.45% | 40.65B | |
+1.89% | 42.59B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.77% | 24.81B | |
-24.07% | 18.17B | |
+29.22% | 12.05B | |
-2.93% | 11.7B | |
+7.07% | 11.1B | |
-17.04% | 9.85B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna : McKesson to replace some Moderna COVID-19 vaccines due to low temperature